Alternance Chargé(e) d’études de marché / Market Research - H/F at Eli Lilly and Company

Neuilly-sur-Seine, Ile-de-France, France

Eli Lilly and Company Logo
Not SpecifiedCompensation
InternshipExperience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • Preparing a master's degree in market research, marketing, or management (business school, university)
  • Analytical mindset, critical thinking, and affinity for numbers to provide strategic and actionable recommendations
  • Autonomous, committed, rigorous, and proactive
  • Dynamic, reactive, able to work cross-functionally/in teams, and attentive to the work environment
  • Creative, curious, and adaptable
  • Fluent in English (written and oral)
  • Good mastery of IT tools (Office suite, Outlook)

Responsibilities

  • Participate in various market studies across different therapeutic areas: analyze internal client needs, identify external partners, set up and monitor studies
  • Provide analytical elements necessary for developing marketing strategy, incorporating performance data from study results
  • Conduct analyses and syntheses of studies, formulate and present recommendations (in French and/or English) to marketing, sales, and medical partners, defending convictions and speaking in front of groups
  • Collaborate closely with sales and marketing teams as well as external service providers

Skills

Market Research
Data Analysis
Marketing Strategy
Customer Needs Analysis
Study Synthesis
Presentation Skills
French
English
Immunology
Diabetes
Obesity

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI